ACADIA PHARMACEUTICALS INC (ACAD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ACAD - US0042251084 - Common Stock

26.15 USD

-0.71 (-2.64%)

Last: 1/27/2026, 2:43:53 PM

Fundamental Rating

ACAD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. ACAD has an excellent financial health rating, but there are some minor concerns on its profitability. ACAD has a correct valuation and a medium growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ACAD had positive earnings in the past year.
In the past year ACAD had a positive cash flow from operations.
ACAD had negative earnings in each of the past 5 years.
ACAD had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ACAD has a Return On Assets of 19.63%. This is amongst the best in the industry. ACAD outperforms 96.95% of its industry peers.
With an excellent Return On Equity value of 28.47%, ACAD belongs to the best of the industry, outperforming 97.52% of the companies in the same industry.
The Return On Invested Capital of ACAD (7.66%) is better than 93.90% of its industry peers.

		Industry Rank	Sector Rank
ROA	19.63%
ROE	28.47%
ROIC	7.66%

ROA(3y)-13.43%

ROA(5y)-20.05%

ROE(3y)-13.54%

ROE(5y)-23.31%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of ACAD (24.94%) is better than 95.05% of its industry peers.
ACAD has a Operating Margin of 9.02%. This is amongst the best in the industry. ACAD outperforms 91.24% of its industry peers.
The Gross Margin of ACAD (91.92%) is better than 93.33% of its industry peers.
In the last couple of years the Gross Margin of ACAD has grown nicely.

		Industry Rank	Sector Rank
OM	9.02%
PM (TTM)	24.94%
GM	91.92%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.57%

GM growth 5Y2.57%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ACAD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ACAD has more shares outstanding than it did 1 year ago.
ACAD has more shares outstanding than it did 5 years ago.
ACAD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 6.07 indicates that ACAD is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 6.07, ACAD is doing good in the industry, outperforming 75.43% of the companies in the same industry.
ACAD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	6.07

ROIC/WACC0.86

WACC8.88%

2.3 Liquidity

A Current Ratio of 3.02 indicates that ACAD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.02, ACAD is doing worse than 63.81% of the companies in the same industry.
A Quick Ratio of 2.94 indicates that ACAD has no problem at all paying its short term obligations.
ACAD has a Quick ratio of 2.94. This is in the lower half of the industry: ACAD underperforms 62.48% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.02
Quick Ratio	2.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ACAD have decreased strongly by -14.10% in the last year.
ACAD shows a strong growth in Revenue. In the last year, the Revenue has grown by 121.75%.

EPS 1Y (TTM)-14.1%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%110%

Revenue 1Y (TTM)121.75%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%11.27%

3.2 Future

Based on estimates for the next years, ACAD will show a very strong growth in Earnings Per Share. The EPS will grow by 39.40% on average per year.
Based on estimates for the next years, ACAD will show a quite strong growth in Revenue. The Revenue will grow by 10.47% on average per year.

EPS Next Y72.27%

EPS Next 2Y29.66%

EPS Next 3Y34.82%

EPS Next 5Y39.4%

Revenue Next Year11.07%

Revenue Next 2Y11.43%

Revenue Next 3Y11.27%

Revenue Next 5Y10.47%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 39.03, the valuation of ACAD can be described as expensive.
Based on the Price/Earnings ratio, ACAD is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.25, ACAD is valued a bit more expensive.
With a Price/Forward Earnings ratio of 32.40, ACAD can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ACAD is valued cheaply inside the industry as 91.81% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 25.98, ACAD is valued a bit more expensive.

		Industry Rank	Sector Rank
PE	39.03
Fwd PE	32.4

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACAD indicates a rather cheap valuation: ACAD is cheaper than 92.95% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ACAD is valued cheaply inside the industry as 95.24% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	20.32
EV/EBITDA	28.66

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACAD has a very decent profitability rating, which may justify a higher PE ratio.
ACAD's earnings are expected to grow with 34.82% in the coming years. This may justify a more expensive valuation.